Published in PLoS One on June 04, 2012
The clinical evaluation of novel imaging methods for cancer management. Nat Rev Clin Oncol (2012) 0.80
The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer. Oncotarget (2016) 0.75
Biomarkers and chemopreventives in oral carcinogenesis and its prevention. J Oral Maxillofac Pathol (2014) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88
Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer (1953) 11.45
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (2011) 11.12
The molecular biology of head and neck cancer. Nat Rev Cancer (2010) 9.84
Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol (1989) 7.47
Head and neck cancer. N Engl J Med (2001) 7.32
TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med (2007) 5.92
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res (2001) 5.78
Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res (2004) 2.95
Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev (2003) 2.76
Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res (2000) 2.34
Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med (2008) 2.24
Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res (2004) 2.07
Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res (Phila) (2009) 1.99
Retracted Oral carcinogenesis and oral cancer chemoprevention: a review. Patholog Res Int (2011) 1.82
Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer. Cancer Prev Res (Phila) (2010) 1.80
Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol (2006) 1.76
Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res (1994) 1.57
Proteomic analysis of field cancerization in pharynx and oesophagus: a prospective pilot study. J Pathol (2010) 1.48
Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy. J Clin Oncol (2008) 1.25
Topical application of a bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesions. Cancer Res (2008) 1.24
Pilot randomized phase II study of celecoxib in oral premalignant lesions. Clin Cancer Res (2008) 1.23
Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines. Clin Cancer Res (2004) 1.13
Current status of biomarkers in head and neck cancer. J Surg Oncol (2008) 0.98
Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo. Clin Cancer Res (2008) 0.96
Chemoprevention of colon carcinogenesis by polyethylene glycol: suppression of epithelial proliferation via modulation of SNAIL/beta-catenin signaling. Mol Cancer Ther (2006) 0.90
Consistent and fast inhibition of colon carcinogenesis by polyethylene glycol in mice and rats given various carcinogens. Cancer Res (2000) 0.90
Polyethylene glycol-mediated colorectal cancer chemoprevention: roles of epidermal growth factor receptor and Snail. Mol Cancer Ther (2008) 0.87
Inhibition of cyclooxygenase-2: an approach to preventing cancer of the upper aerodigestive tract. Ann N Y Acad Sci (2001) 0.87
Polyethylene glycol and prevalence of colorectal adenomas. Gastroenterol Clin Biol (2006) 0.83
Chemoprevention of 4-NQO-induced oral carcinogenesis by co-administration of all-trans retinoic acid loaded microspheres and celecoxib. J Control Release (2005) 0.83
Polyethylene glycol inhibits intestinal neoplasia and induces epithelial apoptosis in Apc(min) mice. Cancer Lett (2004) 0.83
Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia-Pacific region. Histopathology (2002) 0.83
Polyethylene-glycol, a potent suppressor of azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis (1999) 0.82
Inhibition of tumor growth by biodegradable microspheres containing all-trans-retinoic acid in a human head-and-neck cancer xenograft. Int J Cancer (2003) 0.82
Cytostatic effect of polyethylene glycol on human colonic adenocarcinoma cells. Int J Cancer (2001) 0.82
Chemopreventive effect of fermented brown rice and rice bran on 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats. Oncol Rep (2007) 0.80
Involvement of p21cip1/waf1 in the anti-proliferative effects of polyethylene glycol in colon carcinogenesis. Int J Oncol (2010) 0.80
The epidermal growth factor receptor axis: support for a new target for oral premalignancy. Cancer Prev Res (Phila) (2010) 0.77
Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco: implications for screening. Arch Intern Med (2006) 3.32
Is patient travel distance associated with survival on phase II clinical trials in oncology? J Natl Cancer Inst (2003) 3.09
Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ Res (2003) 2.86
Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol (2010) 2.47
The tight junction protein complex undergoes rapid and continuous molecular remodeling at steady state. J Cell Biol (2008) 2.42
Optical methodology for detecting histologically unapparent nanoscale consequences of genetic alterations in biological cells. Proc Natl Acad Sci U S A (2008) 2.33
Intracellular Na(+) concentration is elevated in heart failure but Na/K pump function is unchanged. Circulation (2002) 2.32
Optical markers in duodenal mucosa predict the presence of pancreatic cancer. Clin Cancer Res (2007) 2.10
Partial-wave microscopic spectroscopy detects subwavelength refractive index fluctuations: an application to cancer diagnosis. Opt Lett (2009) 2.04
Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy. Cancer Res (2009) 1.91
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res (2005) 1.75
MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function. Proc Natl Acad Sci U S A (2010) 1.70
Coherent backscattering spectroscopy. Opt Lett (2004) 1.62
Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function. J Cell Biol (2011) 1.58
Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis. Gastroenterology (2010) 1.57
Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk. Ann Epidemiol (2011) 1.57
Nanocytology of rectal colonocytes to assess risk of colon cancer based on field cancerization. Cancer Res (2012) 1.53
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol (2003) 1.52
Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clin Cancer Res (2004) 1.44
Characterization of light transport in scattering media at sub-diffusion length scales with Low-coherence Enhanced Backscattering. IEEE J Sel Top Quantum Electron (2010) 1.33
Light-scattering technologies for field carcinogenesis detection: a modality for endoscopic prescreening. Gastroenterology (2010) 1.33
Role of cytoskeleton in controlling the disorder strength of cellular nanoscale architecture. Biophys J (2010) 1.30
Measuring mucosal blood supply in vivo with a polarization-gating probe. Appl Opt (2008) 1.29
Nanoscale changes in chromatin organization represent the initial steps of tumorigenesis: a transmission electron microscopy study. BMC Cancer (2014) 1.29
Low-coherence enhanced backscattering: review of principles and applications for colon cancer screening. J Biomed Opt (2006) 1.28
Low-coherent backscattering spectroscopy for tissue characterization. Appl Opt (2005) 1.27
HDAC up-regulation in early colon field carcinogenesis is involved in cell tumorigenicity through regulation of chromatin structure. PLoS One (2013) 1.21
Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis. Am J Pathol (2013) 1.20
Polarized Enhanced Backscattering Spectroscopy for Characterization of Biological Tissues at Subdiffusion Length-scales. IEEE J Sel Top Quantum Electron (2012) 1.20
Colorectal cancer risk: black, white, or shades of gray? JAMA (2008) 1.17
Investigating population risk factors of pancreatic cancer by evaluation of optical markers in the duodenal mucosa. Dis Markers (2008) 1.16
Dynamic migration of γδ intraepithelial lymphocytes requires occludin. Proc Natl Acad Sci U S A (2012) 1.11
Outcomes of computerized physician order entry in an electronic health record after implementation in an outpatient oncology setting. J Oncol Pract (2011) 1.11
Modulation of the pancreatic islet beta-cell-delayed rectifier potassium channel Kv2.1 by the polyunsaturated fatty acid arachidonate. J Biol Chem (2006) 1.11
Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome). Arch Intern Med (2004) 1.10
Rectal mucosal microvascular blood supply increase is associated with colonic neoplasia. Clin Cancer Res (2009) 1.09
Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck (2004) 1.08
Depth-resolved low-coherence enhanced backscattering. Opt Lett (2005) 1.07
Spectral markers in preneoplastic intestinal mucosa: an accurate predictor of tumor risk in the MIN mouse. Cancer Epidemiol Biomarkers Prev (2005) 1.06
Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer (2011) 1.06
Assessment of blood supply in superficial tissue by polarization-gated elastic light-scattering spectroscopy. Appl Opt (2006) 1.06
Advances in biophotonics detection of field carcinogenesis for colon cancer risk stratification. J Cancer (2013) 1.06
Down-regulation of the tumor suppressor gene C-terminal Src kinase: an early event during premalignant colonic epithelial hyperproliferation. FEBS Lett (2005) 1.04
Colon cancer screening: the good, the bad, and the ugly. Arch Intern Med (2006) 1.02
Tumor suppressor Foxo3a is involved in the regulation of lipopolysaccharide-induced interleukin-8 in intestinal HT-29 cells. Infect Immun (2008) 1.02
Inducible nitric oxide synthase (iNOS) mediates the early increase of blood supply (EIBS) in colon carcinogenesis. FEBS Lett (2007) 1.01
MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties. J Biol Chem (2007) 1.01
Head and neck cancers. J Natl Compr Canc Netw (2008) 1.01
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer. Clin Cancer Res (2003) 1.00
Retinoic acid-induced gene-1 (RIG-I) associates with the actin cytoskeleton via caspase activation and recruitment domain-dependent interactions. J Biol Chem (2009) 0.99
Tumor suppressor FOXO3 participates in the regulation of intestinal inflammation. Lab Invest (2009) 0.99
Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux. Mol Biol Cell (2013) 0.98
Insights into the field carcinogenesis of ovarian cancer based on the nanocytology of endocervical and endometrial epithelial cells. Int J Cancer (2013) 0.97
Urinary incontinence in young nulligravid women. Ann Intern Med (2013) 0.96
In vivo measurement of the shape of the tissue-refractive-index correlation function and its application to detection of colorectal field carcinogenesis. J Biomed Opt (2012) 0.96
Neo-angiogenesis and the premalignant micro-circulatory augmentation of early colon carcinogenesis. Cancer Lett (2011) 0.95
Tumor suppressor FOXO3 mediates signals from the EGF receptor to regulate proliferation of colonic cells. Am J Physiol Gastrointest Liver Physiol (2010) 0.94
Dysregulation of microRNAs in colonic field carcinogenesis: implications for screening. PLoS One (2012) 0.93
Ultrastructural alterations in field carcinogenesis measured by enhanced backscattering spectroscopy. J Biomed Opt (2013) 0.93
FOXO3 growth inhibition of colonic cells is dependent on intraepithelial lipid droplet density. J Biol Chem (2013) 0.92
Risk of colon cancer in hereditary non-polyposis colorectal cancer patients as predicted by fuzzy modeling: Influence of smoking. World J Gastroenterol (2006) 0.91
Chemoprevention of colon carcinogenesis by polyethylene glycol: suppression of epithelial proliferation via modulation of SNAIL/beta-catenin signaling. Mol Cancer Ther (2006) 0.90
Nanocytology for field carcinogenesis detection: novel paradigm for lung cancer risk stratification. Future Oncol (2011) 0.90
The MUC gene family: their role in the diagnosis and prognosis of gastric cancer. Histol Histopathol (2008) 0.89
Na/Ca exchange function in intact ventricular myocytes. Ann N Y Acad Sci (2002) 0.88
Depth-resolved measurement of mucosal microvascular blood content using low-coherence enhanced backscattering spectroscopy. Biomed Opt Express (2010) 0.88
Pancreatic cancer patients who smoke and drink are diagnosed at younger ages. Clin Gastroenterol Hepatol (2009) 0.88
Antiproliferative effect of sulindac in colonic neoplasia prevention: role of COOH-terminal Src kinase. Mol Cancer Ther (2008) 0.87
Polyethylene glycol-mediated colorectal cancer chemoprevention: roles of epidermal growth factor receptor and Snail. Mol Cancer Ther (2008) 0.87
Workshop on imaging science development for cancer prevention and preemption. Cancer Biomark (2007) 0.87
Biological mechanisms underlying structural changes induced by colorectal field carcinogenesis measured with low-coherence enhanced backscattering (LEBS) spectroscopy. PLoS One (2013) 0.87
Colonoscopy and optical biopsy: bridging technological advances to clinical practice. Gastroenterology (2011) 0.87
Autoimmune hepatitis: diagnostic dilemma in the setting of suspected iron overload. Case Rep Gastrointest Med (2013) 0.86
Quantification of nanoscale density fluctuations using electron microscopy: Light-localization properties of biological cells. Appl Phys Lett (2010) 0.85
Differing roles of protein kinase C-zeta in disruption of tight junction barrier by enteropathogenic and enterohemorrhagic Escherichia coli. Gastroenterology (2004) 0.84
Metastatic basal cell carcinoma: complete response to chemotherapy and associated pure red cell aplasia. Cancer Invest (2006) 0.84
Decreased colorectal cancer and adenoma risk in patients with microscopic colitis. Dig Dis Sci (2011) 0.84
Expression of TNFAIP3 in intestinal epithelial cells protects from DSS- but not TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol (2012) 0.83
Increased cumulative incidence of prostate malignancies in colorectal cancer patients. Int J Gastrointest Cancer (2003) 0.83
Quantification of nanoscale density fluctuations by electron microscopy: probing cellular alterations in early carcinogenesis. Phys Biol (2011) 0.82
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer. Clin Cancer Res (2003) 0.82
In vivo risk analysis of pancreatic cancer through optical characterization of duodenal mucosa. Pancreas (2015) 0.81